Lu M.-C.KO-JEN LISONG-CHOU HSIEHCHENG-HAN WUCHIA-LI YU2021-01-272021-01-2720061684-1182https://www.scopus.com/inward/record.uri?eid=2-s2.0-33847765478&partnerID=40&md5=8838a4eb9600a8f5c58c10ce846ec5d4https://scholars.lib.ntu.edu.tw/handle/123456789/542215[SDGs]SDG3autoantibody; thyroid antibody; anti thyroglobulin; anti-thyroglobulin; antibody; autoantigen; ribonucleoprotein; small cytoplasmic RNA; SSA2 protein, human; adult; aged; aging; article; autoimmune disease; clinical article; clinical feature; controlled study; disease classification; female; hepatitis; human; immunity; leukopenia; male; prognosis; risk assessment; systemic lupus erythematosus; thrombocytopenia; blood; hepatitis; immunology; lupus vulgaris; middle aged; pathology; pathophysiology; retrospective study; systemic lupus erythematosus; thyroid gland; Adult; Aged; Aging; Antibodies; Autoantibodies; Autoantigens; Female; Hepatitis; Humans; Leukopenia; Lupus; Lupus Erythematosus, Systemic; Male; Middle Aged; Retrospective Studies; Ribonucleoproteins; RNA, Small Cytoplasmic; Thrombocytopenia; Thyroid Glandjournal article171649492-s2.0-33847765478